Rank 97 • AI & Clinical Intelligence
Quibim
Applies AI to analyze medical imaging biomarkers, supporting precision medicine and clinical trials in oncology.
Visit website- Signal Score
- 79.5
- Total raised
- $20M
- Stage
- Series A
- Founded
- 2012
- Headquarters
- Valencia, Spain
- Region
- Europe
Their signal
Spain-based Quibim stands out for turning standard imaging scans into quantitative virtual biopsies, collaborating with top global pharmaceutical companies and clinical providers.
Signal Score 79.5editorial estimate, see how it is built
Total raised, quality of investors and recency of the last round.
Revenue trajectory, customer count, hiring and market pull.
Peer-reviewed evidence, FDA/CE clearances and live health-system deployments.
Founder track record, clinical depth on the bench and technical leadership.
Search presence, press coverage, founder and brand reach, and how often the company shows up where buyers look.
Also in AI & Clinical Intelligence
Figures are subjective research desk estimates compiled from public sources and refreshed daily, published as editorial commentary. Company marks are shown for identification only and imply no endorsement or affiliation. Want a correction, an update or removal? and see our corrections and removals policy.